These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 24392736)

  • 1. Liposomes formulated with fMLP-modified cholesterol for enhancing drug concentration at inflammatory sites.
    Qin Y; Li ZW; Yang Y; Yu CM; Gu DD; Deng H; Zhang T; Wang X; Wang AP; Luo WZ
    J Drug Target; 2014 Feb; 22(2):165-74. PubMed ID: 24392736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liposome formulated with TAT-modified cholesterol for enhancing the brain delivery.
    Qin Y; Chen H; Yuan W; Kuai R; Zhang Q; Xie F; Zhang L; Zhang Z; Liu J; He Q
    Int J Pharm; 2011 Oct; 419(1-2):85-95. PubMed ID: 21807083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of liposomes containing the chemotactic peptide N-formyl-methionyl-leucyl-phenylalanine (FMLP) and their interaction with mouse macrophages.
    Nayar R; Morikawa K; Fidler IJ
    Cancer Drug Deliv; 1987; 4(4):233-44. PubMed ID: 3454250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human neutrophil Fc gamma RIIIB and formyl peptide receptors are functionally linked during formyl-methionyl-leucyl-phenylalanine-induced chemotaxis.
    Kew RR; Grimaldi CM; Furie MB; Fleit HB
    J Immunol; 1992 Aug; 149(3):989-97. PubMed ID: 1321856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activation of tumoricidal properties in mouse macrophages using the chemotactic peptide N-formyl-methionyl-leucyl-phenylalanine (FMLP) incorporated in liposomes.
    Morikawa K; Nayar R; Fidler IJ
    Cancer Immunol Immunother; 1988; 27(1):1-6. PubMed ID: 3396025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The main functions and structural modifications of tripeptide N-formyl-methionyl-leucyl-phenylalanine (fMLP) as a chemotactic factor.
    Yang KH; Fang H; Ye JS; Gong JZ; Wang JT; Xu WF
    Pharmazie; 2008 Nov; 63(11):779-83. PubMed ID: 19069235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liposome formulated with TAT-modified cholesterol for improving brain delivery and therapeutic efficacy on brain glioma in animals.
    Qin Y; Chen H; Zhang Q; Wang X; Yuan W; Kuai R; Tang J; Zhang L; Zhang Z; Zhang Q; Liu J; He Q
    Int J Pharm; 2011 Nov; 420(2):304-12. PubMed ID: 21945185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel nano-carriers with N-formylmethionyl-leucyl-phenylalanine-modified liposomes improve effects of C16-angiopoietin 1 in acute animal model of multiple sclerosis.
    Fu XX; Qu H; Wang J; Cai HY; Jiang H; Chen HH; Han S
    Drug Deliv; 2023 Dec; 30(1):2241664. PubMed ID: 37545034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for the presence of N-formyl-methionyl-leucyl-phenylalanine (fMLP) receptor ligands in human amniotic fluid and fMLP receptor modulation by physiological labour.
    Biondi C; Pavan B; Dalpiaz A; Valerio A; Spisani S; Vesce F
    J Reprod Immunol; 2005 Dec; 68(1-2):71-83. PubMed ID: 16236365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Temporal adaptation of neutrophil oxidative responsiveness to n-formyl-methionyl-leucyl-phenylalanine. Acceleration by granulocyte-macrophage colony stimulating factor.
    English D; Broxmeyer HE; Gabig TG; Akard LP; Williams DE; Hoffman R
    J Immunol; 1988 Oct; 141(7):2400-6. PubMed ID: 3049807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of leukotriene B4 on enhancement of superoxide production evoked by formyl-methionyl-leucyl-phenylalanine in myeloid differentiated HL-60 cells: possible involvement of intracellular calcium influx and high affinity receptor for leukotriene B4.
    Harada Y
    Hiroshima J Med Sci; 1990 Sep; 39(3):89-94. PubMed ID: 2178158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A derivative of wheat germ agglutinin specifically inhibits formyl-peptide-induced polymorphonuclear leukocyte chemotaxis by blocking re-expression (or recycling) of receptors.
    Perez HD; Elfman F; Lobo E; Sklar L; Chenoweth D; Hooper C
    J Immunol; 1986 Mar; 136(5):1803-12. PubMed ID: 3753993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2-Phenyl-2,3-dihydro-1H-imidazo[1,2-b]pyrazole derivatives: new potent inhibitors of fMLP-induced neutrophil chemotaxis.
    Bruno O; Brullo C; Bondavalli F; Ranise A; Schenone S; Falzarano MS; Varani K; Spisani S
    Bioorg Med Chem Lett; 2007 Jul; 17(13):3696-701. PubMed ID: 17475488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Removal of human polymorphonuclear leukocyte surface sialic acid inhibits reexpression (or recycling) of formyl peptide receptors. A possible explanation for its effect on formyl peptide-induced polymorphonuclear leukocyte chemotaxis.
    Perez HD; Elfman F; Lobo E
    J Immunol; 1987 Sep; 139(6):1978-84. PubMed ID: 3624873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liposomal pravastatin inhibits tumor growth by targeting cancer-related inflammation.
    Coimbra M; Banciu M; Fens MH; de Smet L; Cabaj M; Metselaar JM; Storm G; Schiffelers RM
    J Control Release; 2010 Dec; 148(3):303-10. PubMed ID: 20869410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deactivation of guinea pig pulmonary alveolar macrophage responses to N-formyl-methionyl-leucyl-phenylalanine: chemotaxis, superoxide generation, and binding.
    Daughaday CC; Mehta J; Spilberg I; Atkinson JP
    J Immunol; 1985 Mar; 134(3):1823-6. PubMed ID: 2981922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic targeted delivery of payload into tumor cells by dual-ligand liposomes co-modified with cholesterol anchored transferrin and TAT.
    Tang J; Zhang L; Liu Y; Zhang Q; Qin Y; Yin Y; Yuan W; Yang Y; Xie Y; Zhang Z; He Q
    Int J Pharm; 2013 Sep; 454(1):31-40. PubMed ID: 23850793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional expression of N-formyl peptide receptors in human bone marrow-derived mesenchymal stem cells.
    Viswanathan A; Painter RG; Lanson NA; Wang G
    Stem Cells; 2007 May; 25(5):1263-9. PubMed ID: 17234990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A pH-responsive α-helical cell penetrating peptide-mediated liposomal delivery system.
    Zhang Q; Tang J; Fu L; Ran R; Liu Y; Yuan M; He Q
    Biomaterials; 2013 Oct; 34(32):7980-93. PubMed ID: 23891517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Signal transduction pathways triggered by selective formylpeptide analogues in human neutrophils.
    Selvatici R; Falzarano S; Mollica A; Spisani S
    Eur J Pharmacol; 2006 Mar; 534(1-3):1-11. PubMed ID: 16516193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.